States Offering Partial GLP-1 Coverage for Obesity: Another 22 states, including Texas, Arizona, and Washington, offer partial coverage for obesity-specific GLP-1s
There's been a meaningful uptick in utilization here [] We have recently launched a program called InCircle Rx, which brings together management of the GLP-1 cardiac diabetic conditions, obesity
Dual GIP/GLP-1 receptor agonists and even triple agonists are currently being tested and might work better because they hit multiple signaling pathways at once
By inhibiting NNMT and preserving NAD, 5-Amino-1MQ indirectly boosts SIRT1 activity , leading to: Increased fat oxidation SIRT1 activates PGC-1 (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), a master regulator of mitochondrial biogenesis and fat metabolism
Landini I, Lapucci A, Pratesi A, Massai L, Napoli C, Perrone G, et al
Noskipping doses disrupts semaglutide's steady-state effect and weakens appetite suppression